Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03300349

Enrollment

276

Registered

2017-10-03

Start date

2017-09-27

Completion date

2017-12-31

Last updated

2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Lymphedema, Shoulder Injury

Keywords

Breast cancer, Breast cancer-related lymphedema, Shoulder injury, Prevention, Educational activity, Physiotherapy

Brief summary

This study aims to determine the effectiveness of the different programmes of four Spanish hospitals about prevention of axillary lymphadenectomy sequels in breast cancer patients.

Detailed description

This study aims to describe the different programs for the prevention of sequels of axillary lymphadenectomy in patients with breast cancer in four Spanish hospitals, to determine the degree of compliance of these programs and to register the frecuency of lymphedema and limitation of mobility of the upper limb in breast cancer patients undergoing axillary lymphadenectomy between 2014 and 2016 in the four hospitals.

Interventions

OTHERFulfillment of a preventive programme

Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder

OTHERNo fulfillment of a preventive programme

No fulfillment of the preventive programme: Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Suffering from axillary lymphadenectomy due to breast cancer treatment between 1 january 2014 until 31 december 2016.

Exclusion criteria

* Lymphedema prior to surgery in any of the upper limbs or any malformation or injury that prevents comparison of both upper limb volumes. * Cognitive impairment or intellectual disability that would prevent understanding the instructions of the study, as well as the purpose of the same. * Serious condition.

Design outcomes

Primary

Measure	Time frame	Description
breast cancer-related lymphedema	The agreed date with the participant for the evaluation (second half of 2017)	Truncated cone formula

Secondary

Measure	Time frame	Description
functional shoulder limitation	The agreed date with the participant for the evaluation (second half of 2017)	Shoulder Pain and Disability Index
Symptoms associated with breast cancer-related lymphedema	The agreed date with the participant for the evaluation (second half of 2017)	Visual Analogic Scale

Other

Measure	Time frame	Description
Degree of compliance with the prevention program	The agreed date with the participant for the evaluation (second half of 2017)	questionnaire

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026